SeveritySigns and symptomsTreatmentSpecial considerations
  • Uninfected

  • Lack of purulent drainage or inflammation

  • Cleanse wound

  • None

  • Mild

  • Cellulitis extending less than 2 cm from the wound and at least two of the following: erythema, induration, pain, purulence, tenderness, or warmth; limited to skin or superficial tissues; no evidence of systemic illness

  • Abscess without surrounding cellulitis: incision and drainage, destruction of loculations, dry dressing

  • Superficial infections (e.g., impetigo, abrasions, lacerations): topical mupirocin (Bactroban); bacitracin and neomycin less effective

  • Deeper infections: oral penicillin, first-generation cephalosporin, macrolide, or clindamycin

  • Topical mupirocin, oral trimethoprim/sulfamethoxazole, or oral tetracycline for MRSA

  • Moderate

  • At least one of the following: cellulitis extending 2 cm or more from wound; deep tissue abscess; gangrene; involvement of fascia; lymphangitis; evidence of muscle, tendon, joint, or bone involvement

  • Cellulitis: five-day course of penicillinase-resistant penicillin or first-generation cephalosporin; clindamycin or erythromycin for patients allergic to penicillin

  • Bite wounds: five- to 10-day course of amoxicillin/clavulanate (Augmentin); doxycycline or trimethoprim/sulfamethoxazole, or fluoroquinolone plus clindamycin for patients allergic to penicillin

  • Trimethoprim/sulfamethoxazole for MRSA; patients who are immunocompromised or at risk of noncompliance may require parenteral antibiotics

  • Severe

  • Acidosis, fever, hyperglycemia, hypotension, leukocytosis, mental status changes, tachycardia, vomiting

  • In most cases, hospitalization and initial treatment with parenteral antibiotics

  • Cellulitis: penicillinase-resistant penicillin, first-generation cephalosporin, clindamycin, or vancomycin

  • Bite wounds: ampicillin/sulbactam (Unasyn), ertapenem (Invanz), or doxycycline

  • Linezolid (Zyvox), daptomycin (Cubicin), or vancomycin for cellulitis with MRSA; ampicillin/sulbactam or cefoxitin for clenched-fist bite wounds

  • Progressive infection despite empiric therapy

  • Spreading of infection, new symptoms (e.g., fever, metabolic instability)

  • Treatment should be guided by results of Gram staining and cultures, along with drug sensitivities

  • Vancomycin, linezolid, or daptomycin for MRSA; consider switching to oral trimethoprim/sulfamethoxazole if wound improves